Heterologous Production of Bacteriocin EMM1 from Pseudomonas Protegens and its Antimicrobial Activity against Multidrug-resistant Clinical Isolates

Edith A. Bernabé-Pérez,Paul Gaytán,Victor Rivelino Juárez-González,Ismael J. Hernández-García,Gabriela Tapia-Pastrana,Verónica Quintero-Hernández,Lucía Lourdes Martínez-Martínez
DOI: https://doi.org/10.1007/s10989-024-10649-z
2024-10-06
International Journal of Peptide Research and Therapeutics
Abstract:Bacteria produce antimicrobial compounds to compete for nutrients and space in particular habitat. Bacteria of the genus Pseudomonas have gained relevance in recent years due to their ability to produce bacteriocins and a wide range of secondary metabolites of medical and agricultural importance, such as 2,4-diacetylphloroglucinol (DAPG), ribosomal peptide synthetase (RPS), pyrrolnitrin (PRN) and pyoluteorin (PLT), which have exhibited antimicrobial properties.
biochemistry & molecular biology
What problem does this paper attempt to address?